Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Infectious prions do not induce Aβ deposition in an in vivo seeding model.

Rasmussen J, Krasemann S, Altmeppen H, Schwarz P, Schelle J, Aguzzi A, Glatzel M, Jucker M.

Acta Neuropathol. 2018 Jun;135(6):965-967. doi: 10.1007/s00401-018-1848-5. Epub 2018 Apr 16. No abstract available.

PMID:
29663066
2.

Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases.

Morales R, Estrada LD, Diaz-Espinoza R, Morales-Scheihing D, Jara MC, Castilla J, Soto C.

J Neurosci. 2010 Mar 31;30(13):4528-35. doi: 10.1523/JNEUROSCI.5924-09.2010.

3.

Distinct patterns of spread of prion infection in brains of mice expressing anchorless or anchored forms of prion protein.

Rangel A, Race B, Phillips K, Striebel J, Kurtz N, Chesebro B.

Acta Neuropathol Commun. 2014 Jan 21;2:8. doi: 10.1186/2051-5960-2-8.

4.

Prion infection of mice transgenic for human APPSwe: increased accumulation of cortical formic acid extractable Abeta(1-42) and rapid scrapie disease development.

Baier M, Apelt J, Riemer C, Gültner S, Schwarz A, Bamme T, Burwinkel M, Schliebs R.

Int J Dev Neurosci. 2008 Nov;26(7):821-4. doi: 10.1016/j.ijdevneu.2008.07.001. Epub 2008 Jul 9.

PMID:
18662767
5.

Anchorless prion protein results in infectious amyloid disease without clinical scrapie.

Chesebro B, Trifilo M, Race R, Meade-White K, Teng C, LaCasse R, Raymond L, Favara C, Baron G, Priola S, Caughey B, Masliah E, Oldstone M.

Science. 2005 Jun 3;308(5727):1435-9.

6.

Unaltered Prion Pathogenesis in a Mouse Model of High-Fat Diet-Induced Insulin Resistance.

Zhu C, Schwarz P, Abakumova I, Aguzzi A.

PLoS One. 2015 Dec 14;10(12):e0144983. doi: 10.1371/journal.pone.0144983. eCollection 2015.

7.

Protease resistance of infectious prions is suppressed by removal of a single atom in the cellular prion protein.

Leske H, Hornemann S, Herrmann US, Zhu C, Dametto P, Li B, Laferriere F, Polymenidou M, Pelczar P, Reimann RR, Schwarz P, Rushing EJ, Wüthrich K, Aguzzi A.

PLoS One. 2017 Feb 16;12(2):e0170503. doi: 10.1371/journal.pone.0170503. eCollection 2017.

8.

Cross-seeding of prions by aggregated α-synuclein leads to transmissible spongiform encephalopathy.

Katorcha E, Makarava N, Lee YJ, Lindberg I, Monteiro MJ, Kovacs GG, Baskakov IV.

PLoS Pathog. 2017 Aug 10;13(8):e1006563. doi: 10.1371/journal.ppat.1006563. eCollection 2017 Aug.

9.

Alzheimer disease and the prion disorders amyloid beta-protein and prion protein amyloidoses.

Price DL, Borchelt DR, Sisodia SS.

Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6381-4. Review. Erratum in: Proc Natl Acad Sci U S A 1993 Oct 1;90(19):9233.

10.

Mouse models for studying the formation and propagation of prions.

Watts JC, Prusiner SB.

J Biol Chem. 2014 Jul 18;289(29):19841-9. doi: 10.1074/jbc.R114.550707. Epub 2014 May 23. Review.

11.

A transgenic model of a familial prion disease.

Harris DA, Chiesa R, Drisaldi B, Quaglio E, Migheli A, Piccardo P, Ghetti B.

Arch Virol Suppl. 2000;(16):103-12. Review.

PMID:
11214912
12.

Medicine. In a first, infected mice recover from prion disease.

Couzin J.

Science. 2003 Oct 31;302(5646):763-5. No abstract available.

PMID:
14593140
13.

Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.

Yoshioka M, Imamura M, Okada H, Shimozaki N, Murayama Y, Yokoyama T, Mohri S.

Microbiol Immunol. 2011 May;55(5):331-40. doi: 10.1111/j.1348-0421.2011.00328.x.

14.

Familial human prion diseases associated with prion protein mutations Y226X and G131V are transmissible to transgenic mice expressing human prion protein.

Race B, Williams K, Hughson AG, Jansen C, Parchi P, Rozemuller AJM, Chesebro B.

Acta Neuropathol Commun. 2018 Feb 20;6(1):13. doi: 10.1186/s40478-018-0516-2.

15.

Rapid and Quantitative Assay of Amyloid-Seeding Activity in Human Brains Affected with Prion Diseases.

Takatsuki H, Satoh K, Sano K, Fuse T, Nakagaki T, Mori T, Ishibashi D, Mihara B, Takao M, Iwasaki Y, Yoshida M, Atarashi R, Nishida N.

PLoS One. 2015 Jun 12;10(6):e0126930. doi: 10.1371/journal.pone.0126930. eCollection 2015.

16.

Mutant PrPSc conformers induced by a synthetic peptide and several prion strains.

Tremblay P, Ball HL, Kaneko K, Groth D, Hegde RS, Cohen FE, DeArmond SJ, Prusiner SB, Safar JG.

J Virol. 2004 Feb;78(4):2088-99.

17.

Recombinant prion protein induces a new transmissible prion disease in wild-type animals.

Makarava N, Kovacs GG, Bocharova O, Savtchenko R, Alexeeva I, Budka H, Rohwer RG, Baskakov IV.

Acta Neuropathol. 2010 Feb;119(2):177-87. doi: 10.1007/s00401-009-0633-x. Epub 2010 Jan 6.

18.

Prion Infectivity Plateaus and Conversion to Symptomatic Disease Originate from Falling Precursor Levels and Increased Levels of Oligomeric PrPSc Species.

Mays CE, van der Merwe J, Kim C, Haldiman T, McKenzie D, Safar JG, Westaway D.

J Virol. 2015 Dec;89(24):12418-26. doi: 10.1128/JVI.02142-15. Epub 2015 Sep 30.

19.

Prion protein transgenes and the neuropathology in prion diseases.

DeArmond SJ, Prusiner SB.

Brain Pathol. 1995 Jan;5(1):77-89. Review.

PMID:
7767493
20.

The neurochemistry of prion diseases.

DeArmond SJ, Prusiner SB.

J Neurochem. 1993 Nov;61(5):1589-601. Review. No abstract available.

PMID:
7901326

Supplemental Content

Support Center